MedTrace Logo

Vitamin D Oral Replacement in Asthma

NCT03686150 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 112

Last updated 2023-04-19

Study results available
· View outcomes & findings →

Summary

The overall objective of the study is to determine the pharmacokinetics of Vitamin D supplementation in children who have asthma and are overweight or obese.

Conditions

  • Asthma
  • Vitamin D Deficiency
  • Pediatric Obesity

Interventions

DIETARY_SUPPLEMENT

Vitamin D3 oral regimen

Vitamin D3 oral regimens supplementation

Sponsors & Collaborators

  • National Institutes of Health (NIH)

    collaborator NIH

  • IDeA States Pediatric Clinical Trials Network

    lead NETWORK

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
6 Years
Max Age
17 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-01-30
Primary Completion
2021-09-30
Completion
2021-09-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03686150 on ClinicalTrials.gov